United Biotech (P) Limited, India : Pharmaceutical Business

::	Research & Development
::	International Collaboration
::	Business Opportunities
::	Latest Events
::	Divisions At a Glance

:: Press Releases

:: In Licensing

:: Out Licensing

Cisplatin Injection BP 50 mg

Indications :

Bladder Cancer

Brain Cancer

Cervical Cancer

Esophageal Cancer

Gastric Cancer

Germ Cell Tumour

Gestational Trophoblastic Neoplasia

Head & Neck Cancer

Non Small Cell Lung Cancer

Lymphoma, Hodgkin's & Non-Hodgkin's Disease

Ovarian Cancer

Testicular Cancer

Prostate Cancer

Dosage :

Metastatic Testicular Tumors : The usual cisplatin dose for the treatment of testicular cancer in combination with other approved chemotherapeutic agents is 20 mg/m² IV daily for 5 days per cycle.

Metastatic Ovarian Tumors : The usual cisplatin dose for the treatment of metastatic ovarian tumors as a single agent 100mg/m² IV per cycle once every 4 week in combination with cyclophosphamide is 75 to 100 mg/m² IV per cycle once every four weeks (DAY 1). The dose of cyclophosphamide should be 600mg/m² IV once every 4 weeks (DAY 1).

Advanced Bladder Cancer : As a single agent 50 - 70 mg/m² IV per cycle once every 3 to 4 weeks.

For heavily pretreated patients : An initial dose of 50 mg/m² per cycle repeated every 4 weeks.

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : Administer with caution.

Packing :

5 Vials of 50 mg

Home

Careers

Site map